Aldeyra Therapeutics: Q4 Earnings Insights

 

Aldeyra Therapeutics ALDX reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Aldeyra Therapeutics beat estimated earnings by 3.57%, reporting an EPS of $-0.27 versus an estimate of $-0.28.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 1.11% increase in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...